Skip to content

Proteomics and genomics combined with CT to predict CVD

Proteomics and genomics combined with CT to predict CVD - PREDICT-CVD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53785
Enrollment
400
Registered
2022-09-21
Start date
2023-01-10
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Adult subjects between 50 and 75 years old. - Subjects at intermediate to high risk for ASCVD - Asymptomatic subjects without cardiac chest pain - Evidence of atherosclerosis on baseline CCTA

Exclusion criteria

Exclusion criteria: - Renal insufficiency, defined as eGFR

Design outcomes

Primary

MeasureTime frame
The main parameter to study will be the total coronary plaque volume progression.

Secondary

MeasureTime frame
• Presence of obstructive stenosis (and number of vessels) • Progression in number of significant (>50%) and severe (>70%) stenoses • Absolute total plaque volume progression (mm3) • Calcified plaque volume progression (mm3) • Non-calcified plaque volume progression (mm3) • Low-attenuation plaque volume progression (mm3) • Change in Pericoronary Adipose Tissue CT-Attenuation (HU) • CAD-RADS progression (yes/no) • Progression in number of high-risk plaque characteristics (yes/no).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)